NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

About this update from Spotlight Group Ab

DanCann PharmaThe Board of Directors hereby convenes an extraordinary general meeting of DanCann Pharma A/S, CVR-no. 39 42 60 05 ("Company"), to be held onTuesday, 21 October 2025 at 09:00 am (CET)at DanCann Pharma A/S' address, Rugvænget 5, 6823 Ansager, DenmarkThe agenda for the extraordinary general meeting is as follows:Proposal to approve the board of directors' resolution of 6 October 2025 to apply for a voluntary delisting of the Company's shares from Spotlight Stock Market and adopt amendments to the Company's articles of association. (proposed by the board of directors)Pursuant to art. 11.20 of the Company's articles of association, the Board of Directors appoints Attorney-at-law Michael Kristensen as chairman of the meeting.Complete agenda:Re 1: Proposal to approve the board of directors' resolution of 6 October 2025 to apply for a voluntary delisting of the Company's shares from Spotlight Stock Market and adopt amendments to the Company's articles of associationThe board of directors of the Company has today resolved to submit an application to Spotlight Stock Market for a voluntary delisting of the Company's shares from Spotlight Stock Market pursuant to section 6.3 of the Spotlight Stock Market Regulations, subject to approval by this extraordinary general meeting by a majority of least 2/3 of the votes cast as well as 2/3 of the share capital represented at the general meeting.Accordingly, it is proposed that the extraordinary general meeting (i) approves the board of directors' resolution to apply for a voluntary delisting of the Company's shares from Spotlight Stock Market and (ii) adopts the amendments to the Company's articles of association set out in mark-up in draft new articles of association attached as Schedule 1 (said amendments enabling the delisting of the Company's shares).The board of directors has carefully evaluated the Company's current circumstances, and the board of directors is of the opinion that the proposed delisting is in the best interest of both the Company and its shareholders, inter alia due to the following reasons:Disproportionate costs and administrative burdens: Maintaining a listing on Spotlight Stock Market imposes significant recurring costs and extensive compliance obligations. Relative to the Company's present size and resources, these requirements have become disproportionate and divert both financial m...

View stock analysis, news, and events for Spotlight Group Ab